On November 13, 2019, CEN Biotech, Inc. announced that Joseph Byrne, the Chief Executive Officer and member of the Board of Directors of the Company, resigned from all positions held with the Company effective November 13, 2019 and the Board of Directors of the Company appointed Bahige (Bill) Chaaban, the Company's President and Chairman of the Board to serve as the Company's Interim Chief Executive Officer effective November 13, 2019. Mr. Chaaban served as the Chief Executive Officer of the Company from the Company's inception in August 2013 until July 2017.